Below are the top 10 Medical Equipment stocks with highest upside potential,
UPDATED TODAY before 4:30 AM ET, based on the difference between current price
and Wall Street analysts average target price. One Chinese company (DHRM) is on
the list. Alpha Pro Tech, Ltd. (AMEX:APT) has the 1st highest upside potential
in this segment of the market. Its upside is 654.3%. Its consensus target price
is $8.75 based on the average of all estimates. MELA Sciences, Inc.
(NASDAQ:MELA) has the 2nd highest upside potential in this segment of the
market. Its upside is 227.4%. Its consensus target price is $11.00 based on the
average of all estimates. Derma Sciences, Inc. (NASDAQ:DSCI) has the 3rd highest
upside potential in this segment of the market. Its upside is 214.9%. Its
consensus target price is $25.00 based on the average of all estimates. Kips Bay
Medical, Inc. (NASDAQ:KIPS) has the 4th highest upside potential in this segment
of the market. Its upside is 155.3%. Its consensus target price is $12.00 based
on the average of all estimates. WorldHeart Corporation (USA) (NASDAQ:WHRT) has
the 5th highest upside potential in this segment of the market. Its upside is
154.2%. Its consensus target price is $3.00 based on the average of all
estimates. IsoRay, Inc. (AMEX:ISR) has the 6th highest upside potential in this
segment of the market. Its upside is 147.5%. Its consensus target price is $2.50
based on the average of all estimates. Vermillion, Inc. (NASDAQ:VRML) has the
7th highest upside potential in this segment of the market. Its upside is
126.7%. Its consensus target price is $9.00 based on the average of all
estimates. Vision-Sciences, Inc. (NASDAQ:VSCI) has the 8th highest upside
potential in this segment of the market. Its upside is 120.6%. Its consensus
target price is $6.00 based on the average of all estimates. Dehaier Medical
Systems Ltd (NASDAQ:DHRM) has the 9th highest upside potential in this segment
of the market. Its upside is 110.4%. Its consensus target price is $9.00 based
on the average of all estimates. iCAD, INC. (NASDAQ:ICAD) has the 10th highest
upside potential in this segment of the market. Its upside is 108.3%. Its
consensus target price is $2.50 based on the average of all estimates.
No comments:
Post a Comment